Enthought in the News | pharmaphorum: 2025 digital transformation budgets: Realigning expectations
The R&D digital transformation (DX) landscape is evolving once again—driven by the rise of generative AI and now AI agents—and budgets need to keep pace. Enthought Chief Operating Officer Michael Connell shares his thoughts via pharmaphorum on how R&D leaders should think about their DX budgets today as pressure increases to deliver measurable outcomes.
Key Takeaways:
➡️ Recalibrate ROI expectations between digital enhancements and digital transformation
➡️ Have a centralized authority who owns the R&D digital transformation budget vs. distributing among siloed business units focused on short-term outcomes
➡️ Establish clear decision-making mechanisms for budget allocation
Read the full article on pharmaphorum here.
Resources about AI and ML in scientific research here.
Related Content
Understanding Surrogate Models in Scientific R&D
Surrogate models are reshaping R&D by making research faster, more cost-effective, and more sustainable.
R&D Innovation in 2025
As we step into 2025, R&D organizations are bracing for another year of rapid-pace, transformative shifts.
Revolutionizing Materials R&D with “AI Supermodels”
Learn how AI Supermodels are allowing for faster, more accurate predictions with far fewer data points.
What to Look for in a Technology Partner for R&D
In today’s competitive R&D landscape, selecting the right technology partner is one of the most critical decisions your organization can make.
Digital Transformation vs. Digital Enhancement: A Starting Decision Framework for Technology Initiatives in R&D
Leveraging advanced technology like generative AI through digital transformation (not digital enhancement) is how to get the biggest returns in scientific R&D.
Digital Transformation in Practice
There is much more to digital transformation than technology, and a holistic strategy is crucial for the journey.
Leveraging AI for More Efficient Research in BioPharma
In the rapidly-evolving landscape of drug discovery and development, traditional approaches to R&D in biopharma are no longer sufficient. Artificial intelligence (AI) continues to be a...
Utilizing LLMs Today in Industrial Materials and Chemical R&D
Leveraging large language models (LLMs) in materials science and chemical R&D isn't just a speculative venture for some AI future. There are two primary use...
Top 10 AI Concepts Every Scientific R&D Leader Should Know
R&D leaders and scientists need a working understanding of key AI concepts so they can more effectively develop future-forward data strategies and lead the charge...
Why A Data Fabric is Essential for Modern R&D
Scattered and siloed data is one of the top challenges slowing down scientific discovery and innovation today. What every R&D organization needs is a data...